|
Delayed
Bombay S.E.
09:36:03 17/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 1,889.10 INR | +8.97% |
|
+11.79% | +32.37% |
| 08-14 | Ipca Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026 | |
| 08-13 | Ipca Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 4.6B | |||||
| 1,052B | |||||
| 627B | - | - | - | ||
| 441B | |||||
| 349B | |||||
| 287B |
Select your edition
All financial news and data tailored to specific country editions
